Novel compound with anti-cancer activity, and method for preparing the same
WO2020060156A1
Antibody for specifically binding to lysyl-trna synthetase n-terminal domain exposed to extracellular membrane
KR20210010236A
Antibody specifically binding to tryptophanyl-tRNA synthetase protein and uses thereof
KR20210001110A
Fragmented NRS polypeptide and use thereof
KR20190124666A
Novel compounds as mTOR inhibitor and uses thereof
KR20200107402A
Fragmented cysteinyl-tRNA synthetase peptide and use thereof
KR102065474B1
3d bioprinter and operating methods thereof
CA3084461A1
Pharmaceutical composition comprising antibody binding specifically to lysyl-trna synthetase n-terminus as effective ingredient for preventing or treating immune cell migration-related disease
KR20200001101A
Method for automated detection and quantification of AIMP2-DX2 signal through RNA silver in situ hybridization
KR20180137427A
Therapeutic agent of immunocyte migration-related diseases and method for screening thereof
KR20190139640A
Composition for preventing or treating solid tumor comprising compound inhibiting interactions between AIMP2-DX2 and K-Ras and novel compound inhibiting interactions between AIMP2-DX2 and K-Ras
KR20190139637A
Composition for preventing or treating cancer comprising novel mTOR inhibitor
BR112019020166A2
antibody that specifically binds to the n-terminal region of lysyl-trna synthetase exposed on the cell membrane
WO2018182284A1
Antibody binding specifically to n-terminal region of lysyl-trna synthetase exposed on cell membrane
KR20190091621A
Pharmaceutical composition for preventing or treating immunocyte migration-related diseases comprising benzo[d]thiazole derivatives
KR20180109645A
Antibody specifically binding to the N-terminal region of lysyl- tRNA synthethase exposed at cell outer membrane
WO2018004321A1
Composition for diagnosing follicular thyroid carcinoma using expression level of aminoacyl-trna synthetase-related protein and method for detecting diagnostic marker
KR20170136454A
Usefulness of Methionyl-tRNA synthetase (MRS) as a prognostic biomarker of lung cancer
KR20170107404A
Novel benzenesulfonamide derivatives and uses thereof
KR20180026154A
Method for screening autophagy modulator and method for diagnosing autophagy-related disease
